Why is Natco Pharma falling/rising?

As of 04-Jul, Natco Pharma Ltd. has experienced a price increase, currently trading at 998.30, which reflects a rise of 24.75 or 2.54%. The stock has shown strong performance recently, outperforming its sector by 2.03% today and achieving a consecutive gain over the last two days with a total return of 7.92%. The stock reached an intraday high of Rs 1003, and it is currently trading above its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below the 200-day moving average. Additionally, there has been a significant increase in investor participation, with delivery volume rising by 231.45% compared to the 5-day average. Despite a year-to-date decline of 28.02%, the company has shown healthy long-term growth, with operating profit increasing at an annual rate of 32.35% and a return on equity (ROE) of 24.8, indicating a very attractive valuation.
In the broader market context, Natco Pharma's short-term return of 12.96% over the past week contrasts sharply with the Sensex, which has declined by 0.74% during the same period. This indicates that Natco Pharma is performing well relative to the broader market. The stock's high institutional holdings at 23.15% suggest that knowledgeable investors are confident in the company's fundamentals, which may contribute to its recent price rise. Furthermore, the stock is trading at a discount compared to its peers' average historical valuations, which may attract more investors looking for value opportunities. Overall, the combination of strong recent performance, positive financial metrics, and favorable investor sentiment has contributed to the stock's upward movement.